Methyldopa can be used in post-myocardial infarction patients, often benefiting those with hypertension, as it lowers blood pressure without significant cardiac workload increase. However, it may not be the first-line treatment due to its potential for side effects, including bradycardia and depression, and should be used cautiously. Careful monitoring is important to manage any adverse effects and ensure effective blood pressure control in these patients.